Alectinib/Aletinib efficacy

Alectinib/Alectinib (Alectinib) is a drug that targets ALK pan> (tyrosine kinase) targeted drugs are mainly used to treat ALK-positive advanced non-small cell lung cancer (NSCLC). It inhibits the activity of the ALK fusion gene and interferes with the signaling pathways of cancer cells, thus preventing the growth and spread of tumor cells. Aletinib/The main function of Alectinib is to target the ALK fusion protein and block its activity in cancer cells. This can effectively inhibit the proliferation and growth of tumor cells and reduce the size of the tumor.